kinase News
Most Popular kinase Story
EntreMed lands $10M deal to fund cancer drug trials
EntreMed ($ENMD) has struck a deal to bring in much-needed capital to support development of its experimental kinase inhibitor for attacking multiple types of cancer. And the Rockville, MD-based drug Read more...
Latest Headlines
- January 23, 2012
- November 21, 2007
- November 14, 2007
- January 8, 2007
- October 4, 2006
- January 26, 2006
- November 29, 2005
- October 24, 2005
- August 31, 2005
- August 9, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
